"Thrombolytic Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts.
Descriptor ID |
D015912
|
MeSH Number(s) |
E02.319.913
|
Concept/Terms |
Thrombolytic Therapy- Thrombolytic Therapy
- Therapeutic Thrombolysis
- Therapeutic Thrombolyses
- Thrombolyses, Therapeutic
- Thrombolysis, Therapeutic
- Therapy, Fibrinolytic
- Fibrinolytic Therapies
- Therapies, Fibrinolytic
- Therapy, Thrombolytic
- Therapies, Thrombolytic
- Thrombolytic Therapies
- Fibrinolytic Therapy
|
Below are MeSH descriptors whose meaning is more general than "Thrombolytic Therapy".
Below are MeSH descriptors whose meaning is more specific than "Thrombolytic Therapy".
This graph shows the total number of publications written about "Thrombolytic Therapy" by people in this website by year, and whether "Thrombolytic Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 2 | 1 | 3 |
1996 | 0 | 1 | 1 |
1997 | 0 | 1 | 1 |
1998 | 1 | 2 | 3 |
1999 | 0 | 2 | 2 |
2000 | 1 | 0 | 1 |
2001 | 1 | 3 | 4 |
2002 | 0 | 1 | 1 |
2003 | 0 | 2 | 2 |
2004 | 0 | 1 | 1 |
2005 | 1 | 2 | 3 |
2006 | 2 | 2 | 4 |
2007 | 1 | 2 | 3 |
2008 | 2 | 0 | 2 |
2009 | 3 | 1 | 4 |
2010 | 1 | 3 | 4 |
2011 | 10 | 1 | 11 |
2012 | 11 | 3 | 14 |
2013 | 8 | 5 | 13 |
2014 | 5 | 3 | 8 |
2015 | 5 | 5 | 10 |
2016 | 6 | 2 | 8 |
2017 | 2 | 0 | 2 |
2018 | 4 | 3 | 7 |
2019 | 4 | 3 | 7 |
2020 | 5 | 6 | 11 |
2021 | 5 | 6 | 11 |
2022 | 1 | 3 | 4 |
2023 | 1 | 5 | 6 |
2024 | 2 | 3 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thrombolytic Therapy" by people in Profiles.
-
Symptomatic Hemorrhage Risks in Stroke Thrombolysis: aDAPTing to Real-World Practice. JAMA Neurol. 2024 Jul 01; 81(7):689-691.
-
Endovascular Versus Medical Management in Distal Medium Vessel Occlusion Stroke: The DUSK Study. Stroke. 2024 Jun; 55(6):1489-1497.
-
Endovascular Versus Medical Therapy in Posterior Cerebral Artery Stroke: Role of Baseline NIHSS Score and Occlusion Site. Stroke. 2024 Jul; 55(7):1787-1797.
-
Outcomes of Bridging Intravenous Thrombolysis Versus Endovascular Therapy Alone in Late-Window Acute Ischemic Stroke. Stroke. 2024 Jul; 55(7):1767-1775.
-
Editors' Note: IV Thrombolysis vs Early Dual Antiplatelet Therapy in Patients With Mild Noncardioembolic Ischemic Stroke. Neurology. 2024 Mar 12; 102(5):e209236.
-
Endovascular Thrombectomy with or without Bridging Thrombolysis in Acute Ischemic Stroke: A Cost-Effectiveness Analysis. Neuroepidemiology. 2024; 58(1):47-56.
-
Challenges to Door-In-Door-Out Time Thresholds for Patients With Stroke-Reply. JAMA. 2023 12 19; 330(23):2306.
-
Who Holds the Clout? Defining the Role of Mechanical Thrombectomy for Lower Extremity DVT. Cardiovasc Intervent Radiol. 2023 11; 46(11):1581-1582.
-
Minimally Invasive Surgery With Thrombolysis for Intracerebral Hemorrhage Evacuation: Bayesian Reanalysis of a Randomized Controlled Trial. Neurology. 2023 10 17; 101(16):e1614-e1622.
-
Safety Outcomes of Mechanical Thrombectomy Versus Combined Thrombectomy and Intravenous Thrombolysis in Tandem Lesions. Stroke. 2023 10; 54(10):2522-2533.